CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Zolbetuximab is being studied as a treatment for people with pancreatic cancer. Most people with pancreatic cancer...
Phase 2
Milan, Italy and 135 other locations
phosphorylase (MTAP)-deleted gastrointestinal, biliary tract, or pancreatic cancers. The study also aims to determine the safety...
Phase 1
Milan, Italy and 76 other locations
or without SBP-101 in subjects previously untreated for metastatic pancreatic ductal adenocarcinoma (PDA), including subjects who have recei...
Phase 2, Phase 3
Milano, Lombardia, Italy and 91 other locations
cancer, gastroesophageal junction cancer (GEJ cancer) or pancreatic cancer. GEJ is where the tube that ...
Phase 1
Milan, Italy and 43 other locations
The purpose of this study is to evaluate the safety and efficacy of a novel RAS(ON) inhibitor compared to standard(s) of care (SOC) treatment.
Phase 3
Milan, Italy and 59 other locations
Conjugate M9140 in Participants with Advanced Non-Small Cell Lung Cancer (Substudy NSCLC);* PROCEADE PanTumor: A Phase 1b/2, Multicenter, O ...
Phase 1, Phase 2
Milan, Italy and 81 other locations
This research is designed to determine if experimental treatment with PARP inhibitor, AZD5305, alone, or in combination with anti-cancer age....
Phase 1, Phase 2
Milan, Italy and 67 other locations
The purpose of this study is to find out whether the study drug, LY4170156, is safe, tolerable and effective in participants with advanced solid tumors...
Phase 1
Milan, Italy and 23 other locations
to assess the safety, tolerability, PK, PD, immunogenicity and anti-tumor activity of zenocutuzumab (MCLA-128) in patients with solid tumors...
Phase 2
Milan, Italy and 64 other locations
While surgery is considered the only potentially curative therapy for pancreatic cancer, 5-year overall survival (OS) is typically ...
Rozzano, Lombardia, Italy
Clinical trials
Research sites
Resources
Legal